The Pathogenesis and Natural History of Sjogren's Disease
Part of paid clinical trials in Bethesda, Maryland.
- Sponsor
- National Institute of Dental and Craniofacial Research (NIDCR)
- Study ID
- NCT01425892
- Status
- Recruiting
Conditions
- Pathogenesis
- Salivary Gland
- Sjogren's Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 16 Years - 100 Years
- Healthy Volunteers
- Not accepted
Study Details
Background: -Sjogren s Disease (formerly: Sjogrens Syndrome, Sj(SqrRoot)(Delta)gren s syndrome) is a disease that affects about 1-4 million Americans. It is more common in women. It mainly affects the glands that produce saliva and tears, leading to dry eyes and dry mouth. The cause of Sjogren s Disease is unknown, but inflammation plays an important role. The purpose of this study is to learn more about Sjogren s Disease. Objectives: -To better understand how Sjogren s Disease begins and how it affects patients so that we can develop better ways to treat them. Eligibility: * Participants must be 16 years of age or older. * They must have a diagnosis of Sjogren s Disease or have at least two symptoms of Sjogren s Disease. Design: * People taking part in the study will come to the NIH Clinical Center for at least three visits. * During these visits, participants will have a medical history and physical exam. They will have oral and dental assessments, and saliva collection. Lab tests (blood and urine) and dry eye exams will be done. Participants will answer questionnaires and have salivary scintigraphy (adults only unless required for diagnosis). * Other optional tests may also be done. Participants may have to come in for additional visits if they have these optional tests or if their disease changes. * The only treatment provided as part of this study is for medical emergencies or complications that occur while you are at NIH for evaluation.
Key Dates
- Start date
- Jan 18, 2012
- Status verified
- Mar 2026
Study Design
- Enrollment
- 300 participants (estimated)
Arms
- Arm: incomplete sjogren'spatients who meet criteria as incomplete sjogren's
- Arm: primary sjogren'spatients who meet criteria for classification for primary sjogren's
- Arm: secondary sjogren'spatients who meet classification criteria for secondary sjogren's
Primary Outcome Measure
Clinical phenotyping of SjD patients and controls over time Collection of samples for concurrent and future laboratory studies related to the pathogenesis Identification of biomarker candidates in SjD [ Time Frame: patients are followed up to 10 years ]
Central Contacts
- Eileen M Pelayo(301) 594-3097
- Zohreh Khavandgar, D.D.S.(301) 496-4486
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | Maryland | 20892 | - |
Find similar trials in Bethesda, MD
Related Studies
- Characterization of Diseases With Salivary Gland InvolvementRecruiting · National Institute of Dental and Craniofacial Research (NIDCR) · Bethesda, Maryland
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren DiseasePHASE2 · Recruiting · National Institute of Dental and Craniofacial Research (NIDCR) · Bethesda, Maryland
- Maternal Autoimmune Disease Research Alliance (MADRA) RegistryRecruiting · Duke University · Durham, North Carolina
- Rheumatology Patient Registry and BiorepositoryRecruiting · Yale University · New Haven, Connecticut